Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)
China
· Delayed Price · Currency is CNY 15.60
+0.21 (1.36%)
Mar 10, 2026, 3:04 PM CST
SHE:300401 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 8,364 | 7,967 | 6,486 | 7,929 | 7,813 | 8,639 | Upgrade
|
| Market Cap Growth | 8.71% | 22.84% | -18.20% | 1.48% | -9.56% | 47.13% | Upgrade
|
| Enterprise Value | 8,600 | 8,285 | 6,437 | 7,902 | 6,922 | 7,460 | Upgrade
|
| Last Close Price | 15.39 | 14.55 | 11.65 | 14.04 | 13.83 | 15.17 | Upgrade
|
| PE Ratio | 29.61 | 25.77 | 33.72 | 20.66 | 16.15 | 32.82 | Upgrade
|
| Forward PE | 27.00 | 6.18 | 6.18 | 6.18 | 6.18 | 6.18 | Upgrade
|
| PS Ratio | 6.74 | 6.41 | 5.93 | 5.59 | 6.99 | 13.10 | Upgrade
|
| PB Ratio | 2.45 | 2.48 | 2.24 | 3.08 | 3.42 | 3.00 | Upgrade
|
| P/TBV Ratio | 2.61 | 2.63 | 2.38 | 3.30 | 3.69 | 3.19 | Upgrade
|
| P/FCF Ratio | 80.98 | - | - | - | - | - | Upgrade
|
| P/OCF Ratio | 15.49 | 17.08 | 40.54 | 21.03 | 15.25 | 20.21 | Upgrade
|
| EV/Sales Ratio | 6.93 | 6.66 | 5.88 | 5.58 | 6.20 | 11.31 | Upgrade
|
| EV/EBITDA Ratio | 16.84 | 17.58 | 21.26 | 17.24 | 14.12 | 26.68 | Upgrade
|
| EV/EBIT Ratio | 25.42 | 26.23 | 37.98 | 19.88 | 15.53 | 31.89 | Upgrade
|
| EV/FCF Ratio | 83.26 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.52 | 0.53 | 0.55 | 0.21 | 0.18 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 3.48 | 3.64 | 5.24 | 1.16 | 0.85 | 0.86 | Upgrade
|
| Debt / FCF Ratio | 17.21 | - | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.07 | 0.09 | 0.03 | -0.01 | -0.04 | -0.39 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.46 | 0.62 | 0.28 | -0.05 | -0.18 | -4.01 | Upgrade
|
| Net Debt / FCF Ratio | 2.28 | -20.80 | -0.99 | 7.80 | 0.43 | 6.73 | Upgrade
|
| Asset Turnover | 0.22 | 0.23 | 0.23 | 0.37 | 0.32 | 0.23 | Upgrade
|
| Inventory Turnover | 0.72 | 0.64 | 0.67 | 1.00 | 0.94 | 0.90 | Upgrade
|
| Quick Ratio | 1.43 | 1.24 | 1.26 | 0.55 | 0.66 | 2.48 | Upgrade
|
| Current Ratio | 2.06 | 1.94 | 1.95 | 1.06 | 1.24 | 3.10 | Upgrade
|
| Return on Equity (ROE) | 9.20% | 10.12% | 7.04% | 15.81% | 19.91% | 11.28% | Upgrade
|
| Return on Assets (ROA) | 3.70% | 3.63% | 2.26% | 6.49% | 7.85% | 5.18% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.79% | 8.40% | 5.59% | 14.53% | 19.66% | 13.45% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.20% | 7.30% | 4.20% | 14.10% | 16.90% | 7.80% | Upgrade
|
| Earnings Yield | 3.61% | 3.88% | 2.97% | 4.84% | 6.19% | 3.05% | Upgrade
|
| FCF Yield | 1.23% | -0.18% | -1.30% | -0.04% | -2.60% | -1.93% | Upgrade
|
| Dividend Yield | 0.74% | 0.78% | 0.61% | 1.00% | 1.36% | 0.68% | Upgrade
|
| Payout Ratio | 30.41% | 21.80% | 53.59% | 31.99% | 13.64% | 3.83% | Upgrade
|
| Buyback Yield / Dilution | 9.28% | 1.07% | -9.65% | -0.85% | -7.38% | -6.04% | Upgrade
|
| Total Shareholder Return | 9.99% | 1.86% | -9.04% | 0.15% | -6.02% | -5.36% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.